Bucci, Tommaso
Shantsila, Alena
Romiti, Giulio Francesco
Teo, Wee-Siong
Park, Hyung-Wook
Shimizu, Wataru
Mei, Davide Antonio
Tse, Hung-Fat
Proietti, Marco
Chao, Tze-Fan
Lip, Gregory Y. H.
David, Chun-Wah Siu
Shimizu, Wataru
Yodogawa, Kenji
Tsutsui, Hiroyuki
Mukai, Yasushi
Tomita, Hirofumi
Horiuchi, Daisuke
Hagii, Joji
Aonuma, Kazutaka
Okumura, Yasuo
Goya, Masahiko
Hirao, Kenzo
Ajioka, Masayoshi
Hagiwara, Nobuhisa
Suzuki, Atsushi
Yamane, Teiichi
Ikeda, Takanori
Yuzawa, Hitomi
Satomi, Kazuhiro
Yazaki, Yoshinao
Fukuda, Keiichi
Kobayashi, Yoshinori
Morita, Norishige
Murohara, Toyoaki
Watanabe, Eiichi
Harada, Masahide
Sakagami, Satoru
Saeki, Takahiro
Kusano, Kengo
Miyamoto, Koji
Miyazaki, Shinsuke
Tada, Hiroshi
Inoue, Koichi
Tanaka, Nobuaki
Koretsune, Yukihiro
Abe, Haruhiko
Kihara, Yasuki
Nakano, Yukiko
Shimizu, Akihiko
Yoshiga, Yasuhiro
Sakamoto, Tomohiro
Okumur, Ken
Takahashi, Naohiko
Shinohara, Tetsuji
Soejima, Kyoko
Takagi, Masahiko
Kawamura, Mitsuharu
Munetsugu, Yumi
Kim, Sung-Hwan
Shim, Jae-Min
Uhm, Jae Sun
Im, Sung Il
Par, Hyoung-Seob
Kim, Jun Hyung
On, Young Keun
Oh, Il-Young
Shin, Seung Yong
Ko, Jum Suk
Park, Jun Beom
Teo, Wee-Siong
Won, Kelvin Cheok-Keng
Lim, Toon-Wei
Foo, David
Chen, Shih-Ann
Chen, Shih-Ann
Chao, Tze-Fan
Lin, Yenn-Jiang
Chung, Fa-Po
Hu, Yu-Feng
Chang, Shil-Lin
Tuan, Ta-Chuan
Liao, Jo-Nan
Li, Cheng-Hung
Huang, Jin-Long
Hsieh, Yu-Cheng
Wu, Tsu-Juey
Liao, Ying-Chieh
Chiang, Cheng-Hung
Hsiao, Hsiang-Chiang
Yeh, Tung-Chen
Lin, Wei-Siang
Lin, Wen-Yu
Kuo, Jen-Yuan
Hong, Chong-Lie
Wu, Yih-Je
Li, Ying-Siang
Tsai, Jui-Peng
Sung, Kuo-Tzu
Chang, Sheng-Hsiung
,
Article History
Received: 6 June 2023
Accepted: 18 October 2023
First Online: 26 October 2023
Competing interests
: GFR reports consultancy for Boehringer Ingelheim and an educational grant from Anthos, outside the submitted work. No fees are directly received personally; WS has received grants from Daiichi Sankyo Co., Ltd. and Nippon Boehringer Ingelheim Co., Ltd.; and remuneration for lectures, presentations, speakers’ bureaus, manuscript writing, or educational events from Daiichi Sankyo Co., Ltd., Nippon Boehringer Ingelheim Co., Ltd., Bristol-Meyers Squibb, K.K., Bayer Yakuhin, Ltd., Pfizer Japan, Inc., Ono Pharmaceutical Co., Ltd., and Medtronic Japan Co., Ltd. HFT: is a consultant/speaker fee and research grants from for Abbott; Amgen; AstraZeneca; Bayer; BMS, Boehringer Ingelheim; Boston Scientific; Daiichi Sankyo; Medtronic; Novartis; Pfizer and Sanofi. MP is national leader of the AFFIRMO project on multimorbidity in AF, which has received funding from the European Union’s Horizon 2020 research and innovation program under grant agreement No 899871; GYHL is a consultant and speaker for BMS/Pfizer, Boehringer Ingelheim, Anthos and Daiichi-Sankyo. No fees are received personally. GYHL is co-principal investigator of the AFFIRMO project on multimorbidity in AF, which has received funding from the European Union’s Horizon 2020 research and innovation program under grant agreement No 899871. All other authors report no disclosures.